|
|
||||||||
Department of Medicine, University of Alberta, Edmonton, and The Salk Institute of Biological Studies, San Diego, California.
A woman with rheumatoid arthritis was treated with penicillamine and developed myasthenia gravis. This drug-induced disease was associated with characteristic autoantibodies to acetylcholine receptor. After discontinuing the drug, her symptoms improved and the antibody titers fell. Penicillamine is now being used much more frequently in the treatment of rheumatoid arthritis and it is likely that this complication will become more prevalent.
Dr. Lindstrom's address is Salk Institute of Biological Studies, P.O. Box 1809, San Diego, CA 921 12.
Accepted for publication August 12, 1977.
This article has been cited by other articles:
![]() |
E. T. Wittbrodt Drugs and Myasthenia Gravis: An Update Arch Intern Med, February 24, 1997; 157(4): 399 - 408. [Abstract] [PDF] |
||||
![]() |
A. K. Afifi and W. E. Bell Tests for Juvenile Myasthenia Gravis: Comparative Diagnostic Yield and Prediction of Outcome J Child Neurol, October 1, 1993; 8(4): 403 - 411. [Abstract] [PDF] |
||||
![]() |
W. Robberecht, J. Bednarik, P. Bourgeois, J. van Hees, and H. Carton Myasthenic Syndrome Caused by Direct Effect of Chloroquine on Neuromuscular Junction Arch Neurol, April 1, 1989; 46(4): 464 - 468. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |